Track topics on Twitter Track topics that are important to you
Medical Research Council20 Park Crescent
Phone: 00 44 (0) 020 7670 5274
Fax: 00 44 (0) 020 7670 5124
Although there are no U.S. Food and Drug Administration (FDA) approvals expected for this week, there are two Adcom meetings. Advisory Committees are used by the agency to obtain independent expert ad...
A meeting has been scheduled by the Circulatory Systems Devices Panel of the FDA's Medical Device Advisory Committee on June -More-
New ScientistWe need to start taking vaping seriously as a way to save livesNew ScientistIt's an unprecedented turnaround. E-cigarettes, once painted as a new and sinister health risk, are now being p...
SummaryCordis Corporation Cordis, a subsidiary of a Cardinal Health Inc., develops and manufactures interventional vascular products in the area of cardiology as well as for use in endovascular surger...
SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPar...
President and CEO of Veniti, Elkins is expected to help Endospan fortify global market development of its NEXUS™ Stent Graft System for Aortic Arch Disease Endospan, ...
The objective of this study is to assess the safety and effectiveness of the Cordis Bilateral AAA device and its Delivery System compared to open surgical repair for the treatment of Abdom...
To evaluate the safety and feasibility of the Cordis Neurovascular Self-Expanding Stent System to facilitate endovascular coil embolization of wide neck saccular intracranial aneurysms. ...
This study will look at the performance of the Cordis S.M.A.R.T.™ CONTROL ™ Nitinol Stent System for the treatment of TASC C & D superficial femoral artery long lesions (up to 22 cm) i...
The primary objective of this study is to compare the safety and effectiveness of the Cordis Nitinol Carotid Stent and Delivery Systems (5.5 F and 7 F) with the ANGIOGUARD XP distal prote...
Feasibility study to assess safety of treating patients with self expanding stent in intracranial arteries.
For more than 50 years, Cordis Corporation, a Johnson & Johnson company, has been a worldwide leader in the development and manufacture of interventional vascular technology. Thro...
Flashpoint Medica, a member of the Omnicom Group (NYSE: OMC), is a full-service professional agency focused on defining a brand's flashpoints by bringing unexpected solutions to ignite a brand's g...
We have published hundreds of Cordis news stories on BioPortfolio along with dozens of Cordis Clinical Trials and PubMed Articles about Cordis for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cordis Companies in our database. You can also find out about relevant Cordis Drugs and Medications on this site too.